Suchergebnisse - "Cohen, Mark S"

PubPharm (10)

1

A novel C-terminal Hsp90 inhibitor KU758 synergizes efficacy in combination with BRAF or MEK inhibitors and targets drug-resistant pathways in BRAF-mutant melanomas

enthalten in: Melanoma research | 2021

von Sanchez, J. | Subramanian, C. | Chanda, M. | +6

2

A novel heat shock protein inhibitor KU757 with efficacy in lenvatinib-resistant follicular thyroid cancer cells overcomes up-regulated glycolysis in drug-resistant cells in vitro

enthalten in: Surgery | 2021

von Subramanian, C. | Gorney, R. | Wang, T. | +5

3

Novel C-terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self-renewal, and epithelial-mesenchymal transition

enthalten in: Molecular oncology | 2020

von Subramanian, C. | Grogan, P. | Wang, T. | +8

4

A novel heat shock protein 90 inhibitor potently targets adrenocortical carcinoma tumor suppression

enthalten in: Surgery | 2020

von Wang, T. | Subramanian, C. | Blagg, B. | +1

CommentIn: Surgery. 2020 Jan;167(1):240. - PMID 31561990

5

Old and New Approaches to Target the Hsp90 Chaperone

enthalten in: Current cancer drug targets | 2020

von Sanchez, J. | Carter, T. | Cohen, M. | +1

6

Synthesis and Biological Evaluation of Novobiocin Core Analogues as Hsp90 Inhibitors

enthalten in: Chemistry (Weinheim an der Bergstrasse, Germany) | 2016

von Byrd, K. | Subramanian, C. | Sanchez, J. | +5

7

Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion

enthalten in: Surgery | 2016

von White, P. | Subramanian, C. | Zhu, Q. | +6

CommentIn: Surgery. 2016 Jan;159(1):151. - PMID 26542768

8

Novel C-terminal Hsp90 inhibitor for head and neck squamous cell cancer (HNSCC) with in vivo efficacy and improved toxicity profiles compared with standard agents

enthalten in: Annals of surgical oncology | 2012

von Cohen, S. | Mukerji, R. | Samadi, A. | +4

ErratumIn: Ann Surg Oncol. 2012 May;19(5):1720 Zhang, Xuan [added]

9

Engineering an antibiotic to fight cancer : optimization of the novobiocin scaffold to produce anti-proliferative agents

enthalten in: Journal of medicinal chemistry | 2011

von Zhao, H. | Donnelly, A. | Kusuma, B. | +7

10

A novel HSP90 modulator with selective activity against thyroid cancers in vitro

enthalten in: Surgery | 2009

von Samadi, A. | Loo, P. | Mukerji, R. | +4

1
[1]